Interactions médicamenteuses
Nivolumab + Siponimod
Gravité: Modérée
Nivolumab and Siponimod: moderate interaction.
Dernière mise à jour
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
Résumé
Nivolumab is a PD-1 checkpoint inhibitor that enhances immune activity and can cause immune-related adverse events, while siponimod sequesters lymphocytes. The combined effect is unpredictable, and corticosteroids used for immune toxicity would add to infection risk. Clinical data on the combination are lacking.
Ce que signifie cette interaction, en termes simples
Nivolumab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Nivolumab belongs to Oncology; Siponimod belongs to Central Nervous System.
Pourquoi elle survient
Pharmacodynamic: opposing immune effects of S1P modulation and PD-1 blockade with unpredictable net result.
Conduite à tenir
Weigh the need for both agents, and monitor lymphocyte counts and for infection and immune-related adverse events if combined.
Questions à poser à votre pharmacien
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Nivolumab et Siponimod, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Essayez Pro+ gratuitement pendant 7 jours sur le web. Sans carte.
Autres interactions de Siponimod
- Cladribine + Siponimod Contre-indiquée
- Fingolimod + Siponimod Contre-indiquée
- Fluconazole + Siponimod Contre-indiquée
- Influenza virus vaccine quadrivalent intranasal + Siponimod Contre-indiquée
- Ponesimod + Siponimod Contre-indiquée
- Siponimod + Thioridazine Contre-indiquée
Autres interactions de Nivolumab
- Nivolumab + Thalidomide Majeure
- Dexamethasone-tobramycin + Nivolumab Modérée
- Dexamethasone + Nivolumab Modérée
- Efgartigimod / hyaluronidase sc + Nivolumab Modérée
- Efgartigimod alfa + Nivolumab Modérée
- Nivolumab + Ponesimod Modérée
Questions fréquentes
Can I take Nivolumab with Siponimod?
MediHelp rates the interaction as moderate. Nivolumab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Nivolumab is a PD-1 checkpoint inhibitor that enhances immune activity and can cause immune-related adverse events, while siponimod sequesters lymphocytes. The combined effect is unpredictable, and corticosteroids used for immune toxicity would add to infection risk. Clinical data on the combination are lacking.
How serious is the interaction between Nivolumab and Siponimod?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Weigh the need for both agents, and monitor lymphocyte counts and for infection and immune-related adverse events if combined.
What other medicines interact with Siponimod?
MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.